Transcriptomics

Dataset Information

0

An immunological signature to predict outcome in patients with triple-negative breast cancer patients with residual disease after neoadjuvant chemotherapy


ABSTRACT: When triple-negative breast cancer (TNBC) patients have residual disease after neoadjuvant chemotherapy (NACT), they have a high risk of metastatic relapse. With immune infiltrate in TNBC being prognostic and predictive of response to treatment, our aim was to develop an immunologic transcriptomic signature using post NACT samples to predict relapse.

ORGANISM(S): Homo sapiens

PROVIDER: GSE185507 | GEO | 2022/09/20

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-05-26 | ST002235 | MetabolomicsWorkbench
2022-10-05 | PXD031929 | Pride
| S-EPMC9434232 | biostudies-literature
2023-01-12 | GSE216333 | GEO
2022-12-30 | E-MTAB-11909 | biostudies-arrayexpress
2023-08-09 | E-MTAB-11375 | biostudies-arrayexpress
2023-08-09 | E-MTAB-11379 | biostudies-arrayexpress
2023-08-18 | E-MTAB-11376 | biostudies-arrayexpress
2023-10-12 | E-MTAB-13069 | biostudies-arrayexpress
2022-12-31 | GSE193707 | GEO